People with epilepsy are at risk for hypertension, atrial fibrillation, and hyperlipidemia; they also have an elevated risk ...
Post-hoc analysis of RAP-219 Phase 2a data showed early onset of action and consistency of median response over the entire ...
Some widely prescribed drugs may quietly affect your memory, focus, and cognitive performance. Here’s how they work, who’s ...
GLP-1s are linked to lower seizure recurrence, hospitalization, and mortality risk than other glucose-lowering drugs in ...
“SCN2A and SCN8A DEEs are devastating conditions with extremely high mortality due to the debilitating seizure burden they ...
Children referred to a first seizure clinic (FSC) see a neurologist epilepsy specialist within one week, according to a study ...
Within the white, clinical walls of a nondescript UNLV lab, a small team of neuroscientists are working on a project with ...
Praxis Precision Medicine said it had completed its pre-new drug application meeting with the Food and Drug Administration for its essential tremor treatment. The company said Thursday it expects to ...
To help scientists learn more about epilepsy, Alan Song has used a Summer Undergraduate Research Fellowship to build a new software package that displays brain activity data for epilepsy in a ...
The Phase III, open-label extension study suggests EPX-100 has a “positive” risk/benefit profile for the treatment of Dravet ...
News-Medical.Net on MSN
Mapping SV2A drug binding offers a path to better epilepsy treatments
A multi-institute team led by St. Jude Children's Research Hospital and UT Southwestern Medical Center investigators ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback